Embryonic transcription factor expression in mice predicts medial amygdala neuronal identity and sex-specific responses to innate behavioral cues

  1. Julieta E Lischinsky
  2. Katie Sokolowski
  3. Peijun Li
  4. Shigeyuki Esumi
  5. Yasmin Kamal
  6. Meredith Goodrich
  7. Livio Oboti
  8. Timothy R Hammond
  9. Meera Krishnamoorthy
  10. Daniel Feldman
  11. Molly Huntsman
  12. Judy Liu
  13. Joshua G Corbin  Is a corresponding author
  1. The George Washington University, United States
  2. Children's National Medical Center, United States
  3. University of Colorado School of Medicine, Aurora, United States

Abstract

The medial subnucleus of the amygdala (MeA) plays a central role in processing sensory cues required for innate behaviors. However, whether there is a link between developmental programs and the emergence of inborn behaviors remains unknown. Our previous studies revealed that the telencephalic preoptic area (POA) embryonic niche is a novel source of MeA destined progenitors. Here, we show that the POA is comprised of distinct progenitor pools complementarily marked by the transcription factors Dbx1 and Foxp2. As determined by molecular and electrophysiological criteria this embryonic parcellation predicts postnatal MeA inhibitory neuronal subtype identity. We further find that Dbx1-derived and Foxp2+ cells in the MeA are differentially activated in response to innate behavioral cues in a sex-specific manner. Thus, developmental transcription factor expression is predictive of MeA neuronal identity and sex-specific neuronal responses, providing a potential developmental logic for how innate behaviors could be processed by different MeA neuronal subtypes.

Article and author information

Author details

  1. Julieta E Lischinsky

    Institute for Biomedical Sciences, The George Washington University, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1664-6642
  2. Katie Sokolowski

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Peijun Li

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Shigeyuki Esumi

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Yasmin Kamal

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Meredith Goodrich

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Livio Oboti

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Timothy R Hammond

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Meera Krishnamoorthy

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Daniel Feldman

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Molly Huntsman

    Department of Pediatrics, University of Colorado School of Medicine, Aurora, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Judy Liu

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Joshua G Corbin

    Center for Neuroscience Research, Children's National Medical Center, Washington DC, United States
    For correspondence
    JCorbin@cnmcresearch.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0122-4324

Funding

National Institute on Drug Abuse (R01 NIDA020140)

  • Joshua G Corbin

Intellectual and Developmental Disabilities Research Center (IDDRC P30HD040677)

  • Joshua G Corbin

National Institute on Deafness and Other Communication Disorders (R01 DC012050)

  • Joshua G Corbin

National Institute on Drug Abuse (F32 DA035754)

  • Katie Sokolowski

Goldwin Foundation Grant for Pediatric Epilepsy

  • Judy Liu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were approved by the Children's National Medical Center's Institutional Animal Care (Animal Welfare Assurance Number: A3338-01) and Use Committee (IACUC) protocols (#00030435) and conformed to NIH Guidelines for animal use. All surgery was performed under ketamine/xylazine cocktail anesthesia, and every effort was made to minimize suffering.

Copyright

© 2017, Lischinsky et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,259
    views
  • 590
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Julieta E Lischinsky
  2. Katie Sokolowski
  3. Peijun Li
  4. Shigeyuki Esumi
  5. Yasmin Kamal
  6. Meredith Goodrich
  7. Livio Oboti
  8. Timothy R Hammond
  9. Meera Krishnamoorthy
  10. Daniel Feldman
  11. Molly Huntsman
  12. Judy Liu
  13. Joshua G Corbin
(2017)
Embryonic transcription factor expression in mice predicts medial amygdala neuronal identity and sex-specific responses to innate behavioral cues
eLife 6:e21012.
https://doi.org/10.7554/eLife.21012

Share this article

https://doi.org/10.7554/eLife.21012

Further reading

    1. Evolutionary Biology
    2. Neuroscience
    Gregor Belušič
    Insight

    The first complete 3D reconstruction of the compound eye of a minute wasp species sheds light on the nuts and bolts of size reduction.

    1. Neuroscience
    Alessandro Piccin, Anne-Emilie Allain ... Angelo Contarino
    Research Article

    Substance-induced social behavior deficits dramatically worsen the clinical outcome of substance use disorders; yet, the underlying mechanisms remain poorly understood. Herein, we investigated the role for the corticotropin-releasing factor receptor 1 (CRF1) in the acute sociability deficits induced by morphine and the related activity of oxytocin (OXY)- and arginine-vasopressin (AVP)-expressing neurons of the paraventricular nucleus of the hypothalamus (PVN). For this purpose, we used both the CRF1 receptor-preferring antagonist compound antalarmin and the genetic mouse model of CRF1 receptor-deficiency. Antalarmin completely abolished sociability deficits induced by morphine in male, but not in female, C57BL/6J mice. Accordingly, genetic CRF1 receptor-deficiency eliminated morphine-induced sociability deficits in male mice. Ex vivo electrophysiology studies showed that antalarmin also eliminated morphine-induced firing of PVN neurons in male, but not in female, C57BL/6J mice. Likewise, genetic CRF1 receptor-deficiency reduced morphine-induced firing of PVN neurons in a CRF1 gene expression-dependent manner. The electrophysiology results consistently mirrored the behavioral results, indicating a link between morphine-induced PVN activity and sociability deficits. Interestingly, in male mice antalarmin abolished morphine-induced firing in neurons co-expressing OXY and AVP, but not in neurons expressing only AVP. In contrast, in female mice antalarmin did not affect morphine-induced firing of neurons co-expressing OXY and AVP or only OXY, indicating a selective sex-specific role for the CRF1 receptor in opiate-induced PVN OXY activity. The present findings demonstrate a major, sex-linked, role for the CRF1 receptor in sociability deficits and related brain alterations induced by morphine, suggesting new therapeutic strategy for opiate use disorders.